Tumour grade was known for 22 840 (61%) women, oestrogen-receptor (ER) status for 35 929 (96%), HER2 status for 18 673 (50%), and Ki-67 status for 6963 (19%). This evidence concerns the gene ERBB2 and neoplasm.